This is the authors' abstract. We don't add key points for this paper.
A 5-year-old female child presented with fever of 1-week duration after visiting a malaria endemic zone without antimalarial prophylaxis. The patient presented with respiratory distress, decreased level of consciousness and high-grade fever. An elevated parasitaemia reaching 800,000/μl was observed. Antimalarial therapy was initiated with artesunate being administered intravenous (IV) along with IV clindamycin. Contrary to the expectations, there was no resolution of fever. Following a week of unresolved fever, the drug therapy was revised and altered to IV quinine dihydrochloride and IV clindamycin. Emergence of non-responsiveness to artesunate in Saudi Arabia is an alarming sign and requires revision of management protocols.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Al-Zaydani et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: